- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | How to invest in America? Vaccinate: BIO rolls out awareness campaign amid rising misinformation | ||
| Mo | TV drug ad spending sinks 19% in Q3 despite football season uptick in September | ||
| Mo | Roche's aging oncology blockbuster Gazyva snares FDA nod to move into lupus nephritis | ||
| Mo | Theravance stands up nOH physician education campaign ahead of pivotal data | ||
| Mo | Merck grows again in Va. with $3B small-molecule drug plant, 500+ potential hires | ||
| 17.10. | Merck KGaA's EMD Serono strikes MFN deal in Trump's fertility treatment pricing push | ||
| 17.10. | Sanofi gets one thumbs up, one thumbs down from Europe's CHMP | ||
| 17.10. | FDA names 9 first recipients of 1- to 2-month priority review vouchers | ||
| 16.10. | Genentech preps for flu season with DTC program offering discounted Xofluza | ||
| 16.10. | Merck's Keytruda follows primary endpoint win in ovarian cancer study with OS triumph | ||
| 16.10. | Novartis advances IgAN efforts with phase 3 win for Fabhalta, plots FDA filing for full approval | ||
| 15.10. | AstraZeneca to spend $445M to boost production of Lokelma at Texas plant | ||
| 15.10. | Real Chemistry, Publicis Health make moves to expand targeted marketing capabilities | ||
| 15.10. | GSK makes nice with antifungal partner Scynexis with $22M payment to resolve trial dispute | ||
| 15.10. | Particle Dynamics melds with former EuroAPI plant to debut new CDMO Codis | ||
| 14.10. | Cabaletta picks up the pace with new commercial chief from Legend, Celgene | ||
| 14.10. | Pfizer scores again in HER2-positive breast cancer, this time with Seagen's Tukysa | ||
| 14.10. | J&J chief Duato expects to find 'common ground' with Trump administration as industry's MFN talks play out | ||
| 14.10. | BioCryst inks $700M Astria buyout to challenge Takeda for rare disease market | ||
| 14.10. | BioNTech's African mRNA vaccine production push gets EU funding boost | ||
| 13.10. | Novo plant hit with FDA's most serious inspection classification, portending possible delays for partners | ||
| 13.10. | BMS cooks up schizophrenia stigma-busting initiative with 'Top Chef' judge Gail Simmons | ||
| 13.10. | FDA adds warning to label of J&J, Legend's Carvykti for potentially fatal intestinal disorder | ||
| 13.10. | German drug delivery specialist LTS grows US footprint with buyout of CDMO Renaissance Lakewood | ||
| 10.10. | Novo shutters cell therapy unit, ending work on potential Type 1 diabetes 'cure' |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .